fluid by phenol/chloroform extraction. DNA was obtained from synovial fluid cells by homogenisation in TRI reagent (Molecular Research Centre, Cincinnati, Ohio, USA). DNA extracts were stored at -800C. DNA extracts were tested for B 19 DNA by a nested PCR assay.8 DNA extracts from positive (viraemic) and negative control sera were included in each run.
The C reactive protein was above 10 mg litre'1 in all but four rheumatoid arthritis patients, providing evidence of rheumatoid disease activity (table) . In serum, 14 of 18 rheumatoid arthritis patients (77%) and eight of 11 non-RA patients (73%) were positive for anti-B19 IgG (table) . In synovial fluid, nine of 18 rheumatoid arthritis patients (50%) and seven of 11 non-RA patients (64%) were positive for anti-B19 IgG ( pulmonary stenosis, the laboratory test showed no polycythaemia.
The diagnosis of gouty arthritis was made by demonstrating crystals in the joint fluid in one patient (case 1), while that for the other five patients was performed according to the American Rheumatism Association preliminary criteria for the classification of acute gouty arthritis. 8 The six patients in the present report had large joint arthritis as the first gouty symptoms, although in general approximately 70% of gouty patients are believed to have great toe arthritis as the first symptom. This tendency was also observed-though less markedly-in the previous reports on the five patients cited above. Thus only in the two cases reported by Ciompi et al were the first joints involved great toes. 6 The tendency of gouty arthritis to occur in large joints in Down syndrome patients remains to be explained. In five of our patients, 24 hour uric acid excretion was relatively low (table) . Whether this tendency is a characteristic of Down syndrome patients should be examined in later studies.
The pretreatment serum urate concentrations of our six Down syndrome patients
were not only higher than the age matched male Down syndrome controls but also higher than age matched male gout patients and control male gouty patients (figure). 
